FATE
Fate Therapeutics Inc.
$2.09
+$0.13(+6.63%)
64
Overall
60
Value
90
Tech
42
Quality
Market Cap
$137.24M
Volume
4.12M
52W Range
$0.91 - $2.88
Target Price
$5.41
EPS Estimates Overview
| Current Quarter | $-0.28 | Next Quarter | $-0.27 |
| Current Year | $-1.03 | Next Year | $-0.98 |
| QoQ Growth | +3.6% | YoY Growth | +4.9% |
| 3Y EPS CAGR | +26.6% | Target Price | $5.41 |
| Consensus | Buy | Upside | +158.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $2.09 | +6.6% | 4.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |